Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2026-01-25 @ 2:19 AM
Study NCT ID:
NCT04033432
Status:
UNKNOWN
Last Update Posted:
2022-04-27
First Post:
2019-07-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Northwestern University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Castration Levels of Testosterone | View |
| None | Castration-Resistant Prostate Carcinoma | View |
| None | Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents | View |
| None | Metastatic Prostate Adenocarcinoma | View |
| None | Progressive Disease | View |
| None | Prostate Carcinoma Metastatic in the Bone | View |
| None | Prostate Carcinoma Metastatic in the Soft Tissue | View |
| None | PSA Progression | View |
| None | Stage IVB Prostate Cancer AJCC v8 | View |
| None | Testosterone Less Than 50 ng/dL | View |
Keywords: